Vitamin D and living in northern latitudes - An endemic risk area for vitamin D deficiency

International Journal of Circumpolar Health

Volumn 67, Issue 2-3, 2008, Pages 164-178

  Huotari, Anne ^a   Herzig, Karl Heinz ^a,b,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Northern latitudes; Vitamin D; Vitamin D deficiency

Indexed keywords

CALCITRIOL RECEPTOR; VITAMIN D;

ARCTIC; BIOSYNTHESIS; BONE MINERALIZATION; DIET; HEALTH CARE POLICY; HUMAN; METABOLISM; NEOPLASM; REVIEW; VITAMIN D DEFICIENCY;

ARCTIC REGIONS; CALCIFICATION, PHYSIOLOGIC; DIET; HUMANS; NEOPLASMS; NUTRITION POLICY; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 46149083738     PISSN: 12399744     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Feldman D, Pike JW, Glorieux F editors. Vitamin D. 2nd ed. San Diego, CA: Academic Press; 2006. 1952 pp.
2. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004;29:664-673.
3. Vieth R. Simple method for determining specific binding capacity of vitamin D- binding protein and its use to calculate the concentration of "free" 1,25-dihydroxyvitamin D. Clin Chem 1994;40:435-441.
4. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005;289:F8-F28.
5. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 1986;78:1296-1301.
6. Mackey SL, Heymont JL, Kronenberg HM, Demay MB. Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid x receptor. Mol Endocrinol 1996;10:298-305.
7. Carlberg C, Seuter S. The Vitamin D Receptor. Dermatol Clin 2007;25:515-523.
8. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005;26: 662-687.
9. Carlberg C. Molecular basis of the selective activity of vitamin D analogues. J Cell Biochem 2003;882:274-281.
10. Masuda S, Jones G. Promise of vitamin D analogues in the treatment of hyperproliferative conditions. Mol Cancer Ther 2006;5:797-808.
11. Need AG. Bone resorption markers in vitamin D insufficiency. Clinica Chimica. Acta 2006;368:48-52.
12. Consensus Development Conference: prophylaxis and treatment of osteoporosis. Am J Med 1991;90: 107-110.
13. Vieth R. The role of vitamin D in the prevention of osteoporosis. Ann Med 2005;37:278-285.
14. Sambrook P, Cooper C. Osteoporosis. Lancet 2006;367:2010-2018
15. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts and prospects. J Clin Invest 2005;115:3318-3325.
16. Lane NE. Epidemiology, etiology and diagnosis of osteoporosis. Am J Obstet Gynecol 2006;194(2 Suppl): S3-S11.
17. Roy DK, Pye SR, Lunt M, O'Neill TW, Todd C, Raspe H et al. Falls explain between-center differences in the incidence of limb fracture across Europe. Bone 2002;31:712-717.
18. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006;17:1726-1733.
19. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293: 2257-2264.
20. Boonen S, Vanderschueren D, Haentjens P, Lips P. Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update. J Intern Med 2006; 259:539-552.
21. Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004;19:370-378.
22. Lilliu H, Pamphile R, Chapuy M, Schulten J, Arlot M, Meunier PJ. Calcium-vitamin D3 supplementation is cost-effective in hip fractures prevention. Maturitas 2003;44:299-305.
23. Holick MF. Vitamin D: importance in the prevention of cancers, type I diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004;79:362-371.
24. Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxf) 2005;62:265-281.
25. Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis and inflammatory bowel disease. Prog Biophys Mol Biol 2006;92:60-64.
26. Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 1998;7:391-395.
27. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR et al. 25-hydroxyvitamin D-1[alpha] -hydroxylase in normal and malignant colon tissue. Lancet 2001;357:1673-1674.
28. Mawer E, Hayes M, Heys S, Davies M, White A, Stewart MF, et al. Constitutive synthesis of 1,25-dihydroxyvitamin D3 by a human small cell lung cancer cell line. J Clin Endocrinol Metab 1994;79:554-560.
29. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000;11:847-852.
30. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980;9:227-231.
31. Freedman DM, Dosemeci M, McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 2002;59:257-262.
32. Grant WB, Garland CF. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 2006; 26:2687-2699.
33. Zhuang S, Burnstein KL. Antiproliferative Effect of 1α,25-Dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent GI accumulation. Endocrinology 1998;139:1197-1207.
34. Blutt SE, Allegretto EA, Pike JW, Weigel NL. 1,25-Dihydroxyvitamin D3 and 9-cls-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in GI. Endocrinology 1997;138:1491-1497.
35. Blutt SE, McDonnell TJ, Polek TC, Weigel NL. Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology 2000; 141:10-17.
36. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004;108:104-108.
37. Pence BC, Buddingh F. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis 1988;9:187-190.
38. Kawaura A, Tanida N, Sawada K, Oda M, Shimoyama T. Supplemental administration of I alpha-hydroxyvitamin D3 inhibits promotion by intrarectal instillation of lithocholic acid in N-methyl-N-nitrosourea-induced colonic tumorigenesis in rats. Carcinogenesis 1989;10: 647-649.
39. Park S, Murphy S, Wilkens L, Nomura A, Henderson B, Kolonel L. Calcium and vitamin d intake and risk of colorectal cancer: the multiethnic cohort study. Am J Epidemiol 2007;165:784-793.
40. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type I diabetes: a birth-cohort study. Lancet 2001;358:1500-1503.
41. Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia 1999; 42:51-54.
42. Pozzilli P, Manfrini S, Crino A, et al. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type I diabetes. Horm Metab Res 2005;37:680-683.
43. Littorin B, Blom P, Scholin A, Arnqvist HJ, Blohmé G, Bolinder J et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type I diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006;49:2847-2852.
44. Viskari H, Kondrashova A, Koskela P, Knip M, Hyöty H. Circulating vitamin D concentrations in two neighboring populations with markedly different incidence of type I diabetes. Diabetes Care 2006;29:1458-1459.
45. VanAmerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr 2004;58:1095-1109.
46. Kampman MT, Wilsgaard T, Mellgren SI. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 2007; 254: 471-477.
47. Lamberg-Allardt C. Vitamin D in foods and as supplements. Prog Biophys Mol Biol 2006;92:33-38.
48. Outila TA, Kärkkäinen MU, Seppänen RH, Lamberg-Allardt CJ. Dietary intake of vitamin D in premenopausal, healthy vegans was insufficient to maintain concentrations of serum 25-hydroxyvitamin D and intact parathyroid hormone within normal ranges during the winter in Finland. J Am Diet Assoc 2000;100:434-441.
49. Laaksi IT, Ruohola JP, Ylikomi TJ, Auvinen A, Haataja RI, Pihlajamäki HK, et al. Vitamin D fortification as public health policy: significant improvement in vitamin D status in young Finnish men. Eur J Clin Nutr 2006;60:1035-1038.
50. Piirainen T, Laitinen K, Isolauri E. Impact of national fortification of fluid milks and margarines with vitamin D on dietary intake and serum 25-hydroxyvitamin D concentration in 4-year-old children. Eur J Clin Nutr 2007;61:123-128.
51. Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 2004;80:1710S-1716.
52. Lamberg-Allardt CJ, Viljakainen H et al. Follow-up study on the vitamin D status in the Finnish population 2002 and 2004. Helsinki: Ministry of Social Affairs and Health; 2006. 49 pp.
53. Holick MF. Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol 2006;92:49-59.
54. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004;89:5387-5391.
55. Whiting SJ, Calvo MS. Dietary recommendations for vitamin D: a critical need for functional end points to establish an estimated average requirement. J Nutr 2005;135:304-309.
56. Hollis BW. Circulating 25-Hydroxyvitamin D Levels Indicative of Vitamin D Sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135:317-322.
57. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28.
58. Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007;85:649-650.
59. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: A global perspective of current status. J Nutr 2005; 135:310-316.
60. Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 2004;89-90:611-614.
61. Vieth R. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr 2006;136:1117-1122.
62. Lamberg-Allardt CJ, Outila TA, Kärkkäinen MU, Rita HJ, Valsta LM. Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe? J Bone Miner Res 2001; 16: 2066-2073.
63. Samuelson G. Dietary habits and nutritional status in adolescents over Europe. An overview of current studies in the Nordic countries. Eur J Clin Nutr 2000; 54 Suppl 1:S21-28.
64. Jorde R, Bonaa KH. Calcium from dairy products, vitamin D intake, and blood pressure: the Tromso Study. Am J Clin Nutr 2000;71:1530-1535.
65. Rapuri PB, Kinyamu HK, Gallagher JC, Haynatzka V. Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women. J Clin Endocrinol Metab 2002;87:2024-2032.
66. Calvo MS, Whiting SJ. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr Rev 2003;61: 107-113.
67. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116:2062-2072.
68. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81: 353-373.
69. Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 years: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007;85: 860-868.
70. Harris S, Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am J Clin Nutr 1998;67:1232-1236.
71. Maxwell JD. Seasonal variation in vitamin D. Proc Nutr Soc 1994;53:533-543.
72. Andersen R, Molgaard C, Skovgaard LT, Brot C, Cashman KD, Chabros E, et al. Teenage girls and elderly women living in northern Europe have low winter vitamin D status. Eur J Clin Nutr 2005,59:533-541.
73. Outila TA, Kärkkäinen MU, Lamberg-Allardt CJ. Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: associations with forearm bone mineral density. Am J Clin Nutr 2001;74:206-210.
74. Gerdhem P, Mallmin H, Akesson K, Obrant KJ. Seasonal variation in bone density in postmenopausal women. J Clin Densitom 2004;7:93-100.
75. Brustad M, Alsaker E, Engelsen O, Aksnes L, Lund E. Vitamin D status of middle-aged women at 65-71 degrees N in relation to dietary intake and exposure to ultraviolet radiation. Public Health Nutr 2004;7:327-335.
76. Brustad M, Sandanger T, Wilsgaard T, Aksnes L, Lund E. Change in plasma levels of vitamin D after consumption of cod-liver and fresh cod-liver oil as part of the traditional north Norwegian fish dish "Molje." Int J Circumpolar Health 2003;62:40-53.
77. Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001;86:1212-1221.
78. Ovesen L, Andersen R, Jakobsen J. Geographical diferences in vitamin D status, with particular reference to European countries. Proc Nutr Soc 2003;62: 813-821.
79. Kauppinen-Mäkelin R, Tähtelä R, Löyttyniemi E, Kärkkäinen J, Välimäki MJ. A high prevalence of hypovitaminosis D in Finnish medical in- and outpatients. J Intern Med 2001;249:559-563.
80. Brox J, Bjornstad E, Olaussen K. Hemoglobin, iron, nutrition and life-style among adolescents in a coastal and an inland community in northern Norway. Int J Circumpolar Health 2003;62:130-141.
81. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985;76:1536-1538.
82. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet 1989;2:1104-1105.
83. Ebeling PR, Sandgren ME, DiMagno EP, Lane AW, DeLuca HF, Riggs BL. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women. J Clin Endocrinol Metab 1992;75:176-182.
84. Carlin AM, Rao DS, Meslemani AM, Genaw JA, Parikh NJ, Levy S et al. Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis 2006;2:98-103.
85. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-693.
86. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-856.
87. Adams JS, Lee G. Gains in bone mineral density with resolution of vitamin D intoxication. Ann Intern Med 1997;127:203-206.
88. Marriott BM. Vitamin D supplementation: A word of caution. Ann Intern Med 1997;127:231-233.
89. Weaver CM, Fleet JC. Vitamin D requirements: current and future. Am J Clin Nutr 2004;80(6 Suppl): 1735S-1739S.
90. Narang NK, Gupta RC, Jain MK. Role of vitamin D in pulmonary tuberculosis. J Assoc Physicians India 1984; 32:185-188.
91. Vieth R, Chan PR, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001;73:288-294.
92. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007;85:6-18.
93. Nordic Council of Ministers. Nordic Nutrition Recommendations 2004. 4th ed. Århus: Nordic Council of Ministers; 2004. 21 pp.
94. Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press; 1997. 448 pp.
95. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327:1637-1642.
96. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-676.
97. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469.
98. Meyer HE, Smedshaug GB, Kvaavik E, Falch JA, Tverdal A, Pedersen JI. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res 2002;17:709-715.
99. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000; 15:1113-1118.
100. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons: a randomized, placebo-controlled clinical trial. Ann Intern Med 1996; 124:400-406.
101. Danish Institute for Food and Veterinary Research; 2005 [cited 2007 Jan 2]. Available from: http://www.foodcomp.dk/fcdb_complist.asp.
102. Kansanterveyslaitos; 2007 [cited 2007 Jan 2]. Available from: http://www.fineli.fi/topfoods.php?lang=fi.
103. Rejnmark L, Jorgensen ME, Pedersen MB, Hansen JC, Heickendorff L, Lauridsen AL, et al. Vitamin D insufficiency in Greenlanders on a westernized fare: ethnic differences in calcitropic hormones between Greenlanders and Danes. Calcif Tissue Int 2004;74:255-263.